304 related articles for article (PubMed ID: 20539088)
21. High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers.
Lambotte O; Pollara J; Boufassa F; Moog C; Venet A; Haynes BF; Delfraissy JF; Saez-Cirion A; Ferrari G
PLoS One; 2013; 8(9):e74855. PubMed ID: 24086385
[TBL] [Abstract][Full Text] [Related]
22. Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection.
Peng BJ; Carlson JM; Liu MKP; Gao F; Goonetilleke N; McMichael AJ; Borrow P; Gilmour J; Heath SL; Hunter E; Bansal A; Goepfert PA
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021907
[TBL] [Abstract][Full Text] [Related]
23. Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B*35Px Renders them to an Exhausted Phenotype in HIV-1 infection.
Elahi S; Shahbaz S; Houston S
PLoS Pathog; 2020 Aug; 16(8):e1008696. PubMed ID: 32760139
[TBL] [Abstract][Full Text] [Related]
24. CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.
Pohlmeyer CW; Buckheit RW; Siliciano RF; Blankson JN
Retrovirology; 2013 Dec; 10():152. PubMed ID: 24330837
[TBL] [Abstract][Full Text] [Related]
25. Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang Y; Chikata T; Kuse N; Murakoshi H; Gatanaga H; Oka S; Takiguchi M
J Virol; 2022 Nov; 96(22):e0124822. PubMed ID: 36326273
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
27. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8
Karimzadeh H; Kiraithe MM; Kosinska AD; Glaser M; Fiedler M; Oberhardt V; Salimi Alizei E; Hofmann M; Mok JY; Nguyen M; van Esch WJE; Budeus B; Grabowski J; Homs M; Olivero A; Keyvani H; Rodríguez-Frías F; Tabernero D; Buti M; Heinold A; Alavian SM; Bauer T; Schulze Zur Wiesch J; Raziorrouh B; Hoffmann D; Smedile A; Rizzetto M; Wedemeyer H; Timm J; Antes I; Neumann-Haefelin C; Protzer U; Roggendorf M
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669837
[TBL] [Abstract][Full Text] [Related]
28. Adaptation of CD8 T cell responses to changing HIV-1 sequences in a cohort of HIV-1 infected individuals not selected for a certain HLA allele.
Roider J; Kalteis AL; Vollbrecht T; Gloning L; Stirner R; Henrich N; Bogner JR; Draenert R
PLoS One; 2013; 8(12):e80045. PubMed ID: 24312453
[TBL] [Abstract][Full Text] [Related]
29. The expansion ability but not the quality of HIV-specific CD8(+) T cells is associated with protective human leucocyte antigen class I alleles in long-term non-progressors.
López M; Peris A; Soriano V; Lozano S; Vicario JL; Rallón NI; Restrepo C; Benito JM
Immunology; 2011 Nov; 134(3):305-13. PubMed ID: 21978000
[TBL] [Abstract][Full Text] [Related]
30. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
[TBL] [Abstract][Full Text] [Related]
31. Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.
Descours B; Avettand-Fenoel V; Blanc C; Samri A; Mélard A; Supervie V; Theodorou I; Carcelain G; Rouzioux C; Autran B;
Clin Infect Dis; 2012 May; 54(10):1495-503. PubMed ID: 22441653
[TBL] [Abstract][Full Text] [Related]
32. Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.
Oniangue-Ndza C; Kuntzen T; Kemper M; Berical A; Wang YE; Neumann-Haefelin C; Foote PK; Hills-Evans K; Reyor LL; Kane K; Gladden AD; Bloom AK; Power KA; Thimme R; Lauer GM; Henn MR; Kim AY; Allen TM
J Virol; 2011 Nov; 85(22):11883-90. PubMed ID: 21880756
[TBL] [Abstract][Full Text] [Related]
33. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
34. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection.
Kosmrlj A; Read EL; Qi Y; Allen TM; Altfeld M; Deeks SG; Pereyra F; Carrington M; Walker BD; Chakraborty AK
Nature; 2010 May; 465(7296):350-4. PubMed ID: 20445539
[TBL] [Abstract][Full Text] [Related]
35. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.
Koeppe JR; Campbell TB; Rapaport EL; Wilson CC
J Acquir Immune Defic Syndr; 2006 Feb; 41(2):140-8. PubMed ID: 16394844
[TBL] [Abstract][Full Text] [Related]
36. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other.
Goulder PJ; Tang Y; Pelton SI; Walker BD
J Virol; 2000 Jun; 74(11):5291-9. PubMed ID: 10799606
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.
Feeney ME; Tang Y; Pfafferott K; Roosevelt KA; Draenert R; Trocha A; Yu XG; Verrill C; Allen T; Moore C; Mallal S; Burchett S; McIntosh K; Pelton SI; St John MA; Hazra R; Klenerman P; Altfeld M; Walker BD; Goulder PJ
J Immunol; 2005 Jun; 174(12):7524-30. PubMed ID: 15944251
[TBL] [Abstract][Full Text] [Related]
38. A therapy-related point mutation changes the HLA restriction of an HIV-1 Pol epitope from A2 to B57 and enhances its recognition.
Mason RD; Grant MD
AIDS; 2005 Jun; 19(9):981-4. PubMed ID: 15905682
[TBL] [Abstract][Full Text] [Related]
39. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression.
Buggert M; Norström MM; Salemi M; Hecht FM; Karlsson AC
J Immunol; 2014 May; 192(10):4685-96. PubMed ID: 24740510
[TBL] [Abstract][Full Text] [Related]
40. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
